Empagliflozin vs Fremanezumab

## Empagliflozin vs Fremanezumab: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Fremanezumab**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Fremanezumab — N/A.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Fremanezumab — N/A.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Fremanezumab — N/A.

**Type**: Empagliflozin — Small molecule; Fremanezumab — Antibody.